HEADACHE
HEADACHE
HEADACHE
1) MIGRAINE
a. Migraine without aura
b. Migraine with aura :
● Typical aura with migraine headache (aura lasting less than 1
hour)
● Typical aura with nonmigraine headache
● Typical aura without headache
● Familial hemiplegic migraine
● Sporadic hemiplegic migraine
● Basilar-type migraine
c. Childhood periodic syndromes that are commonly precursors of migraine
● Cyclical vomiting (self-limiting episodic condition)
● Abdominal migraine (episodic midline abdominal pain attacks
lasting 1 to 72 hours)
● Benign paroxysmal vertigo of childhood (brief episodic vertigo)
d. Retinal migraine (repeated attacks of monocular visual disturbance)
e. Complications of migraine
● Chronic migraine (occurring on 15 or more days per month for
more than 3 months)
● Status migrainosus (debilitating attack lasting for more than 72
hours)
● Persistent aura without infarction (symptoms persisting for more
than 1 week)
● Migrainous infarction (aura symptoms associated with an ischemic
brain lesion)
● Migraine-triggered seizure
f. Probable migraine
● Probable migraine without aura
● Probable migraine with aura
● Probable chronic migraine
CLUSTER HEADACHES
MIGRAINE HEADACHE
Triggers of migraine
Pathogenesis
1) GENERAL
● Migraine is a common, recurrent, severe headache that interferes with normal
functioning. It is a primary headache disorder divided into two major subtypes,
migraine without aura and migraine with aura.
2) SYMPTOMS
●Migraine is characterized by recurring episodes of throbbing head pain,
frequently unilateral, that when untreated can last from 4 to 72 hours.
Migraine headaches can be severe and associated with nausea, vomiting,
and sensitivity to light, sound, and/or movement
3) LABORATORY TESTS
● In selected circumstances and secondary headache presentation, serum
chemistries, urine toxicology profiles, thyroid function tests, lyme studies, and
other blood tests such as a complete blood count, antinuclear antibody titer,
erythrocyte sedimentation rate, and antiphospholipid antibody titer may be
considered.
4) DIAGNOSTIC TESTS
Check for abnormalities:
● vital signs (fever, hypertension), funduscopy (papilledema, hemorrhage, and
exudates),
● palpation and auscultation of the head and neck (sinus tenderness, hardened
or tender temporal arteries,
● trigger points,
● temporomandibular joint tenderness, bruits, nuchal rigidity, and cervical spine
tenderness), and
● neurologic examination (identify abnormalities or deficits in mental status,
cranial nerves, deep tendon reflexes, motor strength, coordination, gait, and
cerebellar function).
A) Goals of therapy
● Goals of Long-Term Migraine Treatment
I. Reduce migraine frequency, severity, and disability
II. Reduce reliance on poorly tolerated, ineffective, or unwanted acute
pharmacotherapies
III. Improve quality of life
IV. Prevent headache
V. Avoid escalation of headache medication use
VI. Educate and enable patients to manage their disease
VII. Reduce headache-related distress and psychological symptoms
● Goals for Acute Migraine Treatment
I. Treat migraine attacks rapidly and consistently without recurrence
II. Restore the patient’s ability to function
III. Minimize the use of backup and rescue medications
IV. Optimize self-care for overall management
V. Be cost-effective in overall management
VI. Cause minimal or no adverse effects
B) Nonpharmacological therapy
● Apply ice to the head and recommend periods of rest or sleep, usually in a
dark, quiet environment.
● A headache diary that records the frequency, severity, and duration of
attacks can facilitate identification of migraine triggers.
● Identify and avoid triggers of migraine attacks
● Patients also can benefit from adherence to a wellness program that
includes regular sleep, exercise, and eating habits, smoking cessation,
and limited caffeine intake
● .Behavioral interventions (relaxation therapy, biofeedback, and cognitive
therapy) may help patients who prefer nondrug therapy or when drug
therapy is ineffective or not tolerated.